Multiple Endocrine Neoplasia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Conditions: Medullary Thyroid Carcinoma; Multiple Endocrine Neoplasia Type 2A; Multiple Endocrine Neoplasia Type 2BIntervention: Drug: VandetanibSponsors: National Cancer Institute (NCI); National Institutes of Health Clinical Center (CC)Active, not recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2007 Category: Research Source Type: clinical trials
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Conditions: Medullary Thyroid Carcinoma; Multiple Endocrine Neoplasia Type 2A; Multiple Endocrine Neoplasia Type 2BIntervention: Drug: VandetanibSponsors: National Cancer Institute (NCI); National Institutes of Health Clinical Center (CC)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2007 Category: Research Source Type: clinical trials
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Conditions: Medullary Thyroid Carcinoma; Multiple Endocrine Neoplasia Type 2A; Multiple Endocrine Neoplasia Type 2BIntervention: Drug: VandetanibSponsors: National Cancer Institute (NCI); National Institutes of Health Clinical Center (CC)Active, not recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2007 Category: Research Source Type: clinical trials
